Marie Jardine Yeats
About Marie Jardine Yeats
Marie Jardine Yeats serves as the Vice President of Quality Assurance at Lyndra Therapeutics, where she has worked since 2020. She has extensive experience in the pharmaceutical industry, having held various roles at Alkermes and Goodwin Biotechnology, and holds a Master of Science in Pharmaceutical Quality and Good Manufacturing Practice from the University of Strathclyde.
Current Role at Lyndra Therapeutics
Marie Jardine Yeats serves as the Vice President of Quality Assurance at Lyndra Therapeutics since 2020. In this role, she oversees the Quality Assurance department, ensuring compliance with industry standards and regulations. She manages and presents Quality Assurance metrics, which are critical for maintaining product quality and safety. Additionally, she leads initiatives related to data integrity and manages the Supplier Quality Management (SQM) program, contributing to the overall quality framework of the organization.
Previous Experience at Alkermes
Prior to her current position, Marie Jardine Yeats held multiple roles at Alkermes. She worked as the Associate Director of Development QA from 2014 to 2015 and as the Director of Development QA from 2015 to 2019. During her tenure, she focused on quality assurance processes and compliance, enhancing the development quality systems within the organization. She also served as a QA Specialist in Development QA from 2010 to 2014, where she gained significant experience in quality management.
Educational Background
Marie Jardine Yeats studied at the University of Strathclyde, where she earned a Master of Science (M.S.) in Pharmaceutical Quality and Good Manufacturing Practice from 2010 to 2013. She also pursued her undergraduate studies at Regis College, obtaining a Bachelor of Arts (B.A.) in Biology, General, starting in 1995. Her educational background provides a strong foundation in quality assurance and regulatory compliance within the pharmaceutical industry.
Expertise in Quality Assurance
Marie Jardine Yeats possesses expertise in commissioning, qualifying, and implementing electronic Quality Systems. She has a comprehensive understanding of both US and EU Good Manufacturing Practices (GMP), which is essential for ensuring compliance in pharmaceutical manufacturing. Her experience includes supporting Chemistry, Manufacturing, and Controls (CMC) development and clinical phase products, highlighting her role in the product lifecycle from development to market.
Early Career Experience
Marie Jardine Yeats began her career in the biotechnology field, working as a Cell Culture Technician at Goodwin Biotechnology, Inc. from 1999 to 2001. She also held a position as a Manufacturing Associate - Cell Culture at EMD Serono, Inc. from 1995 to 1996. These early roles provided her with foundational knowledge in biotechnology processes and quality assurance, which she has built upon throughout her career.